These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23218434)

  • 1. Cost of rheumatic disorders in the Netherlands.
    van den Akker-van Marle ME; Chorus AM; Vliet Vlieland TP; van den Hout WB
    Best Pract Res Clin Rheumatol; 2012 Oct; 26(5):721-31. PubMed ID: 23218434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis.
    Boonen A; van den Heuvel R; van Tubergen A; Goossens M; Severens JL; van der Heijde D; van der Linden S
    Ann Rheum Dis; 2005 Mar; 64(3):396-402. PubMed ID: 15271773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of illness studies in rheumatic diseases.
    Fautrel B; Guillemin F
    Curr Opin Rheumatol; 2002 Mar; 14(2):121-6. PubMed ID: 11845016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic impact of the rheumatic diseases in the United States.
    Felts W; Yelin E
    J Rheumatol; 1989 Jul; 16(7):867-84. PubMed ID: 2527991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update: direct and indirect costs of arthritis and other rheumatic conditions--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 May; 53(18):388-9. PubMed ID: 15138399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011.
    Mangen MJ; Bouwknegt M; Friesema IH; Haagsma JA; Kortbeek LM; Tariq L; Wilson M; van Pelt W; Havelaar AH
    Int J Food Microbiol; 2015 Mar; 196():84-93. PubMed ID: 25528537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of rheumatologic disorders.
    Sangha O; Stucki G
    Curr Opin Rheumatol; 1997 Mar; 9(2):102-5. PubMed ID: 9135912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden of multimorbidity among older adults: impact on healthcare and societal costs.
    Picco L; Achilla E; Abdin E; Chong SA; Vaingankar JA; McCrone P; Chua HC; Heng D; Magadi H; Ng LL; Prince M; Subramaniam M
    BMC Health Serv Res; 2016 May; 16():173. PubMed ID: 27160080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of work injuries and diseases: a framework and application in five European Union countries.
    Tompa E; Mofidi A; van den Heuvel S; van Bree T; Michaelsen F; Jung Y; Porsch L; van Emmerik M
    BMC Public Health; 2021 Jan; 21(1):49. PubMed ID: 33407315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct, indirect and intangible costs of acute hand and wrist injuries: A systematic review.
    Robinson LS; Sarkies M; Brown T; O'Brien L
    Injury; 2016 Dec; 47(12):2614-2626. PubMed ID: 27751502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of costs of acute rheumatic fever and rheumatic heart disease in Auckland.
    North DA; Heynes RA; Lennon DR; Neutze J
    N Z Med J; 1993 Sep; 106(964):400-3. PubMed ID: 8377955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resource utilization and cost of rheumatic fever.
    Terreri MT; Ferraz MB; Goldenberg J; Len C; Hilário MO
    J Rheumatol; 2001 Jun; 28(6):1394-7. PubMed ID: 11409136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone and joint diseases around the world. Sweden: a brief update on burden and priority.
    Akesson K
    J Rheumatol Suppl; 2003 Aug; 67():38-40. PubMed ID: 12926652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of stroke in The Netherlands from a societal perspective.
    Evers SM; Engel GL; Ament AJ
    Stroke; 1997 Jul; 28(7):1375-81. PubMed ID: 9227686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic burden of specific learning disability: A prevalence-based cost of illness study of its direct, indirect, and intangible costs.
    Karande S; D'souza S; Gogtay N; Shiledar M; Sholapurwala R
    J Postgrad Med; 2019; 65(3):152-159. PubMed ID: 31169134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Societal perspective on the burden of migraine in The Netherlands.
    van Roijen L; Essink-Bot ML; Koopmanschap MA; Michel BC; Rutten FF
    Pharmacoeconomics; 1995 Feb; 7(2):170-9. PubMed ID: 10155303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Economic cost of treating the patient with asthma in Spain: the AsmaCost study].
    Martínez-Moragón E; Serra-Batllés J; De Diego A; Palop M; Casan P; Rubio-Terrés C; Pellicer C;
    Arch Bronconeumol; 2009 Oct; 45(10):481-6. PubMed ID: 19525051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What are the costs of childhood-onset rheumatic disease?
    Minden K
    Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):223-40. PubMed ID: 16546054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect costs associated with early exit from work attributable to rheumatic diseases.
    Laires PA; Canhão H; Gouveia M
    Eur J Public Health; 2015 Aug; 25(4):677-82. PubMed ID: 25634954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.